TEVAGRASTIM 30 MUI/0.5 ml, solution for injection or infusion syringe, 0.5 ml, parallel import (BB Farma)
Active ingredients: Filgrastim
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection or infusionsyringe, 0.5 ml, parallel import (BB Farma)intraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TEVAGRASTIM 30 MUI/0,5 ml, solution injectable ou pour perfusion
- Pharmaceutical form
- solution injectable ou pour perfusion
- Route of administration
- intraveineuse;sous-cutanée
- Presentation description
- 1 seringue(s) préremplie(s) en verre de 0,5 ml avec aiguille(s) avec dispositif de sécurité (distributeur parallèle : BB Farma)
- Marketing authorisation holder
- TEVA (ALLEMAGNE)
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 18 Sept 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60583187CIP74950128CIP133400949501281Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FILGRASTIMsolution | 300 microgrammes · une seringue préremplie de 0,5 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.